Acta Medica Okayama 75巻 1号
2021-02 発行
Shiotani, Toshio
Department of Organ Transplant Center, Okayama University Hospital
Araki, Kota
Department of General Thoracic Surgery, Okayama University Hospital
Tomioka, Yasuaki
Department of Organ Transplant Center, Okayama University Hospital
Miyoshi, Kentaroh
Department of General Thoracic Surgery, Okayama University Hospital
Kaken ID
Otani, Shinji
Department of General Thoracic Surgery, Okayama University Hospital
Yamane, Masaomi
Department of General Thoracic Surgery, Okayama University Hospital
Kaken ID
researchmap
Although chronic kidney disease (CKD) commonly develops after lung transplantation (LT), living-donor kid-ney transplantation (LDKT) for CKD after LT is known to provide favorable outcomes. We describe the long-term follow-up findings of a patient who underwent LDKT after bilateral cadaveric LT. A 37-year-old male underwent LDKT for CKD 18 years after receiving bilateral cadaveric LT. He developed chronic lung allograft dysfunction (CLAD) 20 years after the LT; however, at 26 years after the initial LT, he is still alive with no pro-gression of CLAD or CKD. KT could be a viable option for CKD even after LT in Japan.
lung transplantation
kidney transplantation
chronic kidney disease
non-tuberculous mycobacterial infection
chronic lung allograft dysfunction